Scientists at St. Jude Children's Research Hospital today report how lifesaving childhood cancer treatments leave ...
Tracking how blood cancers develop over time has uncovered important genetic differences between patients whose disease stays ...
A retired Ullapool teacher is set to cycle the Etape Loch Ness, for a charity that supported him through his son’s ...
This approval provides patients with a new generic option for the folate analog metabolic inhibitor, which is used to treat ...
The Brighterside of News on MSN
25-year-long study discovers how blood cancers evolve and worsen
Some blood cancers move with eerie patience. A patient can feel well for years, their blood counts looking steady, their ...
Remedy Plan Therapeutics, a clinical-stage biotechnology company developing novel therapies that target fundamental metabolic vulnerabilities in disease, today announced that multiple abstracts will ...
Oxford, UK – 16th April 2026 - Alethio Therapeutics, a biopharmaceutical company developing novel treatments for myeloproliferative neoplasms ...
Researchers found that NIH funding for major US cancers does not consistently align with lethality, with highly fatal cancers ...
Tracking how blood cancers develop over time has uncovered important genetic differences between patients whose disease stays stable while others ...
MedPage Today on MSN
High Response Rates in Platinum-Resistant Ovarian Cancer With Immunotherapy Agents
Also from SGO: p53 reactivator active in advanced gynecologic cancers, "perfect" score in ...
Bruker Corporation (Nasdaq: BRKR) today announced new updates from Bruker Spatial Biology to be showcased at the 2026 ...
Remedy Meds is an online consumer health and pharmacy platform that provides access to compounded glucagon-like peptide-one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results